Mucosal Delivery of Biopharmaceuticals : Biology, Challenges and Strategies /
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY :
Springer US : Imprint: Springer,
2014.
|
| Edition: | 1st ed. 2014. |
| Subjects: |
Table of Contents:
- Concepts in Mucosal Immunity and Mucosal Vaccines
- Mucoadhesion and Characterization of Mucoadhesive Properties
- Mucus as a Barrier for Biopharmaceuticals and Drug Delivery Systems
- Epithelial Permeation and Absorption Mechanisms of Biopharmaceuticals
- Oral Delivery of Biopharmaceuticals
- Buccal Delivery of Biopharmaceuticals: Vaccines and Allergens
- Pulmonary Delivery of Biopharmaceuticals
- Nasal Delivery of Biopharmaceuticals
- Ocular Delivery of Biopharmaceuticals
- Vaginal Delivery of Biopharmaceuticals
- Nanoparticles-in-Microsphere Oral Delivery Systems (NiMOS) for Nucleic Acid Therapy in the Gastrointestinal Tract
- Bacteria-Based Vectors for Oral Gene Therapy
- Self-Assembled Polysaccharide Nanogels for Nasal Delivery of Biopharmaceuticals
- Pheroid™ Vesicles and Microsponges for Nasal Delivery of Biopharmaceuticals
- Delivery Strategies for Developing siRNA-Based Vaginal Microbicides
- Delivery Strategies for Developing Vaginal DNA Vaccine Combining Cell-Penetrating Peptides and Jet Injection
- Vaccine Delivery Systems for Veterinary Immunization
- Eligen® Technology for Oral Delivery of Proteins and Peptides
- The RapidMist™ System for Buccal Delivery of Insulin
- The Pharmaceutical Development of rhDNase (Dornase Alpha) for the Treatment of Cystic Fibrosis
- Development of the Exubera® Insulin Pulmonary Delivery System
- Technosphere®: An Inhalation System for Pulmonary Delivery of Biopharmaceuticals
- ChiSys® as a Chitosan-Based Delivery Platform for Nasal Vaccination
- Development of a Cationic Nanoemulsion Platform (Novasorb®) for Ocular Delivery
- Regulatory Aspects and Approval of Biopharmaceuticals for Mucosal Delivery: Quality, Toxicology and Clinical Aspects.